IP Library Granted Patent US 11,007,367
Granted Patent B2
US 11,007,367 · App. 15/071,912 · Granted May 18, 2021

Microcurrent device for the treatment of visual disease

Inventor: George D. O'Clock (Waconia, MN)
Assignee: NOVA OCULUS CANADA MANUFACTURING ULC
A61N1/36046A61N1/36014A61N1/36034A61N1/0408
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,007,367
App. No.
15/071,912
Granted
May 18, 2021
Kind
B2
Abstract

An electrotherapeutic device for treating a visual disease using microcurrent stimulation is provided. The device includes a signal generator in which a waveform controller digitally controls a waveform signal source so as to generate a waveform in which one or more waveform parameters (e.g., pulse width, pulse period, pulse position, pulse coding, peak current amplitude, duty cycle, and/or pulse shape) are varied in accordance with a protocol for treating a visual disease. The device also includes an applicator connected to the signal generator and configured to apply the waveform to at least one stimulation point within an eye region.

Claims (23)

1. An electrotherapeutic device for treating a visual disease using microcurrent stimulation, comprising:

a signal generator comprising (a) a waveform signal source configured to provide a waveform comprising a series of current pulses having a peak current amplitude between 1 microamp and 450 microamps and (b) a waveform controller connected to the waveform signal source and programmed to generate a digital control signal that determines a plurality of waveform parameters for the waveform in accordance with a visual disease treatment protocol, wherein one of the waveform parameters comprises a frequency that is selectively varied to cause the waveform signal source to provide the current pulses at a plurality of varying frequencies within a defined frequency range, wherein another one of the waveform parameters comprises a pulse width that is selectively varied to cause the waveform signal source to provide the current pulses at a plurality of varying pulse widths, and wherein the waveform signal source is configured to receive the digital control signal and provide the waveform so that the frequency and the pulse width of the current pulses are varied simultaneously within the waveform during a treatment session; and

an applicator connected to the signal generator and including an electrode configured to receive and apply the waveform within an eye region during the treatment session.

2. The electrotherapeutic device of claim 1 , wherein the defined frequency range is 0.3 Hz to 300 Hz.

3. The electrotherapeutic device of claim 2 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

4. The electrotherapeutic device of claim 2 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

5. The electrotherapeutic device of claim 1 , wherein the defined frequency range is 0.1 Hz to 50 Hz.

6. The electrotherapeutic device of claim 5 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

7. The electrotherapeutic device of claim 5 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

8. The electrotherapeutic device of claim 1 , wherein the defined frequency range is 0.05 Hz to 10 Hz.

9. The electrotherapeutic device of claim 8 , wherein the current pulses are provided at 75% or more of the discrete frequencies within the defined frequency range.

10. The electrotherapeutic device of claim 8 , wherein the current pulses are provided at 90% or more of the discrete frequencies within the defined frequency range.

11. The electrotherapeutic device of claim 1 , wherein another one of the varied waveform parameters comprises one of peak current amplitude, duty cycle, and pulse shape.

12. The electrotherapeutic device of claim 11 , wherein the waveform comprises a first pulse sequence and a second pulse sequence.

13. The electrotherapeutic device of claim 12 , wherein the signal generator further comprises a waveform sequence controller that varies a polarity of each of the first and second pulse sequences is varied to generate a bipolar waveform.

14. The electrotherapeutic device of claim 13 , wherein the varied waveform parameters of the first pulse sequence are the same as the varied waveform parameters of the second pulse sequence.

15. The electrotherapeutic device of claim 13 , wherein the varied waveform parameters of the first pulse sequence are different than the varied waveform parameters of the second pulse sequence.

16. The electrotherapeutic device of claim 1 , wherein the visual disease comprises macular degeneration.

17. The electrotherapeutic device of claim 1 , wherein the applicator comprises a probe configured to apply the waveform to the stimulation point and a counter electrode configured for attachment to a body part.

18. The electrotherapeutic device of claim 1 , wherein the current pulses have a peak current amplitude between 1 microamp and 450 microamps.

19. The electrotherapeutic device of claim 1 , wherein the current pulses have a peak current amplitude between 180 microamps and 220 microamps.

20. The electrotherapeutic device of claim 1 , wherein the waveform has an average current between 70 microamps and 200 microamps.

21. The electrotherapeutic device of claim 1 , wherein the waveform has an average current between 90 microamps and 100 microamps.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2022
From: NOVA OCULUS CANADA MANUFACTURING ULC
To: MACUMIRA MEDICAL DEVICES INC.
Reel/Frame 060854/0782 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2017
From: NOVA OCULUS PARTNERS, LLC
To: NOVA OCULUS HOLDING CO., INC.
Reel/Frame 043604/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2017
From: NOVA OCULUS HOLDING CO., INC.
To: NOVA OCULUS CANADA MANUFACTURING ULC
Reel/Frame 043604/0579 →
CHANGE OF NAME Recorded Mar 16, 2017
From: THE EYE MACHINE, LLC
To: NOVA OCULUS PARTNERS, LLC
Reel/Frame 042022/0262 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2016
From: O'CLOCK, GEORGE D.
To: THE EYE MACHINE, LLC
Reel/Frame 038003/0761 →
Continuity (1)
Related Publication 20170266445A1 · Sep 21, 2017
Cited By (2)
US 12,280,254 US 12,370,364